Protective effects and metabolomics analysis of dihydromyricetin on cyclophosphamide-induced hepatotoxicity in mice
Cyclophosphamide (CTX) is a chemotherapeutic agent with cytotoxic and immunosuppressive activity. It is used to treat a wide variety of cancers and autoimmune diseases. However, side effects caused by its toxic metabolites, especially hepatotoxicity, limit its clinical application. The natural dihyd...
Saved in:
| Main Authors: | Fei Teng, Haina Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-12-01
|
| Series: | Pharmaceutical Science Advances |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2773216925000017 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protective effects of dihydromyricetin against radiation-induced injury to the hematopoietic system
by: Xiao Sun, et al.
Published: (2025-06-01) -
Does dihydromyricetin protect the kidney following ischemia–reperfusion injury in male rats?
by: Fayez T. Hammad, et al.
Published: (2025-06-01) -
MDA-MB-231 cell apoptosis in vitro induced by dihydromyricetin
by: ZHOU Fang-zhen, et al.
Published: (2012-05-01) -
Hepatotoxicity Induced by Methyl Eugenol: Insights from Toxicokinetics, Metabolomics, and Gut Microbiota
by: Liang Chen, et al.
Published: (2024-10-01) -
Anti-hyperglycemic effects of dihydromyricetin in streptozotocin-induced diabetic rats
by: Maojun Yao, et al.
Published: (2021-03-01)